00:00It's Benzinga, and here's what's on the block.
00:02All seven independent directors of 23andMe resigned from the board, citing disagreements
00:07with CEO Ann Wojcicki regarding the company's strategic direction.
00:11Wojcicki expressed disappointment in the resignations, but reaffirmed her commitment to taking the
00:15genetic testing company private despite a rejected proposal in July.
00:19The special committee found no actionable proposal benefiting non-affiliated shareholders.
00:2423andMe, which went public via a SPAC in 2021, has seen its share price drop over 95%,
00:30closing at $0.34 on Tuesday.
00:32For all things money, visit Benzinga.com.
Comments